XETRA:GXI

Gerresheimer AG · XETRA · Healthcare · EUR · FY for 2025

Figures on this page computed 2026-11-08 13:44 UTC

Last close

n/aEUR

Market data

  • n/aP/E

    We do not hold this figure for this company, so there is nothing to place.

    Price / Earnings per Share (diluted)

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • computed
    • Computed from the filing for 2025
  • n/aROIC

    We do not hold this figure for this company, so there is nothing to place.

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • -13.8%Net margin

    Net Income / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • -4.3%FCF margin

    Free Cash Flow / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 1.48Debt/equity

    Total Debt / Shareholders' Equity

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 0.2%Dividend yield
    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • computed

Follow one euro

lens 1 of 9
After what it costs to make
18.3%
After running the business
-9.0%
After interest and tax
-13.8%
After what it must reinvest
-4.3%
Kept after the dividend
-4.4%
after what it costs to make, 18.3% of sales; after running the business, -9.0% of sales; after interest and tax, -13.8% of sales; after what it must reinvest, -4.3% of sales; kept after the dividend, -4.4% of sales

The five stops

5 of 5 read
  • After what it costs to make425,252,00018.3%
  • After running the business-209,321,000-9.0%
  • After interest and tax-320,316,000-13.8%
  • After what it must reinvest-98,797,000-4.3%
  • Kept after the dividend-101,146,000-4.4%

Of every unit of sales, -0.04 is still there after the dividend.

Of every unit of sales, -0.04 is still there after the dividend.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

  • Sales2,320,885,000
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    EUR
  • After what it costs to make425,252,000
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    EUR
  • After running the business-209,321,000
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    EUR
  • After interest and tax-320,316,000
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    EUR
  • After what it must reinvest-98,797,000
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    EUR
  • Kept after the dividend-101,146,000
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    EUR

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.